6.2.2
OPAL1 ................................................................................................................. 34
6.2.3
Display (Live menu) ............................................................................................. 35
6.3 Setup menu ..................................................................................................................... 36
6.3.1
Display (Setup menu) .......................................................................................... 39
6.3.2
Network .............................................................................................................. 40
6.4 Patient data privacy ......................................................................................................... 42
7.1 Maintenance .................................................................................................................... 46
7.2.1
Visual inspection ................................................................................................. 46
7.2.2
Electric measurements ....................................................................................... 46
7.3 Repairing the product ...................................................................................................... 46
8.1 Accessories ..................................................................................................................... 48
9.3 Table 1 - Compliance level for immunity tests ................................................................ 54
9.4 Table 2 - Test levels for proximity fields from HF wireless communications equipment 55
9.5 Table 3 - Test levels for radiated and conducted immunity tests ................................... 56
9.6 Table 4 - Emission class and group ................................................................................ 57
9.7 Table 5 - Recommended separation distances between portable and mobile HF
communications devices and the product ...................................................................... 58
10 Subsidiaries .............................................................................................................................. 59
Instructions for use • IMAGE1 S • 705LZA_EN_V2.1_05-2022_IFU_FDA
Table of contents
4